The Genetic Basis of Disease

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/25

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 9:58 AM on 4/15/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

26 Terms

1
New cards

Affected het

Dominant phenotype

2
New cards

Unaffected het

Recessive phenotype

3
New cards

Example of dominant inheritance

Achondroplasia

4
New cards

Achondroplasia

Mutation of the FGF receptor. It is usually turned off however in achondroplasia is it always turned on.

5
New cards

Example of recessive inheritance

Phenylketonuria

6
New cards

Phenylketonuria

Results from deficiency of phenylalanine hyroxylase - enzyme that catalyses the hyroxylation of phenylalanine to tryosine.

7
New cards

Why are males more likely to be colour blind than females?

Because the red and green opsin genes are on the X chromosome, and males have only one X; any mutation in their single R or G opsin gene causes colour blindness, whereas females have two X chromosomes so a normal allele usually compensates.

8
New cards

Sickle cell disorder

  • Caused by a mutation in the gene encoding beta-globin

  • Under low O2 conditions, HbS (haemoglobin sickle) forms long aggregates which distort the shape of RBCs

  • Affected cells can’t pass through narrow blood vessels, leading to a sickling crisis.

9
New cards

How does sickle cell gene therapy work?

  1. Stem cells are extracted

  2. Stem cells are genetically modified

  3. These cells are re-injected to the patient

  4. Stem cells make halethy foetal haemoglobin and normal RBCs

10
New cards

SMA

  • Caused by mutations in the SMN1 gene

  • Severe neuromuscular disorder - death of motor neurones and progressive muscle wasting

11
New cards

Gene therapy for SMA

Nusinersin blocks SMN2 exon 7 skipping so more functional SMN2 protein made which can compensate for loss of SMN1 function

12
New cards

Penetrance

The frequency with which a genotype manifests itself in a given phenotype.

13
New cards

λ

The risk ration - the higher the number, the more cloesely related the group is to the person with disease (increasing indicates increased risk)

14
New cards

Monogenic

Caused by mutation in a single gene

15
New cards

Polyphagia

Abnormally strong, incessant sensation of hunfer or desire to eat

Its not a disorder itself but a sympton indication an underlying medical condition

16
New cards

Single nucleotide polymorphism (SNP)

Locus where different individuals have a different DNA base in their genomic sequence.

Generally a disease associated SNP does not directly cause the disease

17
New cards

Germline

The germ cells (gametes) and those that give rise to them

Can be passed onto subsequent generations

18
New cards

Somatic cell

Any cell in the body that is not part of the germline

Cannot be passed on through generations

19
New cards

Oncogenes

  • Promote cell division

  • When mutated in cancers, usually have a dominant effect

20
New cards

Tumour suppressor genes

  • Inhibit cell division, protect against DNA damage

  • When mutated in cancers, usually have a recessive phenotype

21
New cards

What type of mutation converts a proto-oncogene into an oncogene?

A dominant gain of function mutation

22
New cards

What type of mutation inactivates tumour suppressor genes?

a recessive loss of function mutation

23
New cards

Why do tumour suppressor gene mutations act recessively?

Both gene copies must be inactivated to lose function

24
New cards

Knudson’s two hit hypothesis

In order for a particular cell to become cancerous, both of the cell’s tumour suppressor genes must be mutated

25
New cards

What is bcr-abl fusion protein?

A fusion of the bcr and abl genes that creates an abnormally active tyrosine kinase driving tumour cell survival and proliferation leading to cancer such as chronic myeloid leukamia

26
New cards

How does Imatinib (Gleevec) inhibit the bcr-abl fusion protein?

It competitively binds to the bcr-abl kinase domain, blocking substrate access and preventing phosphorylation, which stops tumour cell proliferation